BIT 0.00% 3.3¢ biotron limited

Ann: BIT225 Effectiveness Against COVID-19 in Animals, page-63

  1. 20,216 Posts.
    lightbulb Created with Sketch. 1782
    This is what say,

    https://www.abbvie.com/our-science/covid-19-research-development.html

    And we’re working with global health authorities, government health officials, universities and other biopharmaceutical companies to help address the medical impacts of the pandemic.

    COVID R&D Alliance

    AbbVie is proud to be part of the COVID R&D Alliance, joining forces with others in the industry to help in the fight against COVID-19. Together we are working to identify, study, and accelerate the most promising therapeutic drug candidates.

    AbbVie’s COVID-19 R&D efforts

    As a global biopharmaceutical company, AbbVie is committed to addressing the COVID-19 public health crisis. We are collaborating with health authorities and institutions globally to identify potential treatments, including supporting clinical studies and basic research of our medicines. We’re also collaborating with industry, government, and academia, focusing on early science and discovery research.

    As for J8, I was taught to say nothing if you have nothing good to say!
    Last edited by moosey: 17/03/22
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
3.3¢
Change
0.000(0.00%)
Mkt cap ! $29.77M
Open High Low Value Volume
3.4¢ 3.4¢ 3.1¢ $74.61K 2.300M

Buyers (Bids)

No. Vol. Price($)
4 280031 3.2¢
 

Sellers (Offers)

Price($) Vol. No.
3.4¢ 96500 1
View Market Depth
Last trade - 15.22pm 12/07/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.